Clinical Trial Update: Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bioequivalence of two tamsulosin HCl capsule formulations in fasted male subjects completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Tamsulosin HCl (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2020-03-26